- Home
- GNW vs XENE Comparison
GNW vs XENE Comparison
Compare GNW & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNW
- XENE
- Stock Information
- Founded
- GNW 1871
- XENE 1996
- Country
- GNW United States
- XENE Canada
- Employees
- GNW N/A
- XENE N/A
- Industry
- GNW Life Insurance
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- GNW Finance
- XENE Health Care
- Exchange
- GNW Nasdaq
- XENE Nasdaq
- Market Cap
- GNW 3.5B
- XENE 2.9B
- IPO Year
- GNW 2004
- XENE 2014
- Fundamental
- Price
- GNW $8.64
- XENE $38.22
- Analyst Decision
- GNW Buy
- XENE Strong Buy
- Analyst Count
- GNW 1
- XENE 10
- Target Price
- GNW $10.00
- XENE $52.90
- AVG Volume (30 Days)
- GNW 4.3M
- XENE 798.2K
- Earning Date
- GNW 11-05-2025
- XENE 11-03-2025
- Dividend Yield
- GNW N/A
- XENE N/A
- EPS Growth
- GNW 512.33
- XENE N/A
- EPS
- GNW 0.44
- XENE N/A
- Revenue
- GNW $7,261,000,000.00
- XENE $7,500,000.00
- Revenue This Year
- GNW N/A
- XENE N/A
- Revenue Next Year
- GNW N/A
- XENE $207.88
- P/E Ratio
- GNW $17.71
- XENE N/A
- Revenue Growth
- GNW N/A
- XENE N/A
- 52 Week Low
- GNW $5.99
- XENE $26.74
- 52 Week High
- GNW $9.15
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- GNW 53.01
- XENE 39.57
- Support Level
- GNW $8.29
- XENE $37.63
- Resistance Level
- GNW $8.94
- XENE $39.41
- Average True Range (ATR)
- GNW 0.21
- XENE 1.51
- MACD
- GNW 0.02
- XENE -0.64
- Stochastic Oscillator
- GNW 55.56
- XENE 14.98
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.